MBX Biosciences, Inc. (MBX) Insider Trading
Directors, officers and holders of more than 10% of MBX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 162 transactions on file: 5 with code P, 5 with code S and 40 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Radovich Peter | Director | A Award | 18,200 | Not measured | Not measured |
| Aug 4, 2026 | Azoulay Salomon | Chief Medical Officer | S Sale | 370 | $65.77 | $24,335 |
| Aug 3, 2026 | Smither John W | Chief Financial Officer | A Award | 28,000 | Not measured | Not measured |
| Aug 3, 2026 | Smither John W | Chief Financial Officer | A Award | 130,000 | Not measured | Not measured |
| Aug 3, 2026 | Hoerter Steven L. | President and CEO | A Award | 71,000 | Not measured | Not measured |
| Aug 3, 2026 | Hoerter Steven L. | President and CEO | A Award | 331,000 | Not measured | Not measured |
| Jun 4, 2026 | Ryder Steven | Director | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Heron Patrick J | Director | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Hoerter Steven L. | President and CEO | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Pescovitz Ora H. | Director | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Stelzer Laurie | Director | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Aynechi Tiba | Director | A Award | 12,500 | Not measured | Not measured |
| Jun 4, 2026 | Mathers Edward T | Director | A Award | 12,500 | Not measured | Not measured |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | M Exercise | 15,003 | Not measured | Not measured |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | M Exercise | 55,000 | $10.46 | $575,300 |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | M Exercise | 55,000 | Not measured | Not measured |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | M Exercise | 15,003 | $16.00 | $240,048 |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | S Sale | 15,003 | $38.30 | $574,615 |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | S Sale | 55,000 | $38.38 | $2,110,900 |
| May 6, 2026 | Hawryluk P. Kent | President & CEO | S Sale | 607 | $29.54 | $17,931 |
| May 6, 2026 | Azoulay Salomon | Chief Medical Officer | S Sale | 231 | $29.54 | $6,824 |
| May 1, 2026 | Hoerter Steven L. | President and CEO | A Award | 74,249 | Not measured | Not measured |
| May 1, 2026 | Hoerter Steven L. | President and CEO | A Award | 11,938 | Not measured | Not measured |
| Mar 13, 2026 | Hawryluk P. Kent | President & CEO | P Purchase | 18,500 | $28.41 | $525,663 |
| Feb 26, 2026 | Hawryluk P. Kent | President & CEO | M Exercise | 28,768 | $16.00 | $460,288 |
| Feb 26, 2026 | Hawryluk P. Kent | President & CEO | M Exercise | 28,768 | Not measured | Not measured |
| Feb 2, 2026 | Bartram Richard | Chief Financial Officer | A Award | 70,000 | Not measured | Not measured |
| Feb 2, 2026 | Azoulay Salomon | Chief Medical Officer | A Award | 70,000 | Not measured | Not measured |
| Feb 2, 2026 | Hawryluk P. Kent | President & CEO | A Award | 164,500 | Not measured | Not measured |
| Feb 2, 2026 | Hawryluk P. Kent | President & CEO | A Award | 35,250 | Not measured | Not measured |
| Feb 2, 2026 | Bartram Richard | Chief Financial Officer | A Award | 15,000 | Not measured | Not measured |
| Feb 2, 2026 | Azoulay Salomon | Chief Medical Officer | A Award | 15,000 | Not measured | Not measured |
| Jan 20, 2026 | Stelzer Laurie | Director | A Award | 32,000 | Not measured | Not measured |
| Nov 22, 2025 | Hoerter Steven L. | President and CEO | A Award | 8,000 | Not measured | Not measured |
| Nov 22, 2025 | Hoerter Steven L. | President and CEO | A Award | 0 | Not measured | Not measured |
| Nov 6, 2025 | Hoerter Steven L. | President and CEO | A Award | 33,751 | Not measured | Not measured |
| Nov 6, 2025 | Hoerter Steven L. | President and CEO | A Award | 100,000 | Not measured | Not measured |
| Oct 24, 2025 | Hawryluk P. Kent | President & CEO | M Exercise | 182,859 | Not measured | Not measured |
| Oct 24, 2025 | Hawryluk P. Kent | President & CEO | M Exercise | 182,859 | $3.25 | $594,292 |
| Oct 20, 2025 | Hawryluk P. Kent | President & CEO | P Purchase | 20,000 | $13.64 | $272,790 |
| Oct 17, 2025 | Hoerter Steven L. | President and CEO | P Purchase | 20,000 | $13.25 | $264,984 |
| Sep 26, 2025 | Heron Patrick J | Director | P Purchase | 666,666 | $18.00 | $11,999,988 |
| Jun 5, 2025 | CORNELIUS JAMES M | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Ryder Steven | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Pescovitz Ora H. | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Aynechi Tiba | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Heron Patrick J | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Mathers Edward T | Director | A Award | 16,000 | Not measured | Not measured |
| Jun 5, 2025 | Hoerter Steven L. | President and CEO | A Award | 16,000 | Not measured | Not measured |
| Apr 8, 2025 | Pescovitz Ora H. | Director | P Purchase | 7,693 | $5.89 | $45,312 |
The full Form 4 history is on the MBX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.